HIGHLIGHTS
- who: January and collaborators from the Montreal University, Canada have published the paper: Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China, in the Journal: (JOURNAL)
- what: A study of physicians showed that clinicians over 50 became more conservative about switching to biosimilars (57%); they thought biosimilars were Frontiers in Pharmacology Limitations and future perspectives This study had several limitations. The study only focused on a single indication and one biological agent.
- how: The regression results showed that older patients (p . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.